Morgan Stanley Analysts Give Lanxess (ETR:LXS) a €64.00 Price Target

Share on StockTwits

Lanxess (ETR:LXS) has been given a €64.00 ($74.42) target price by stock analysts at Morgan Stanley in a research report issued on Friday, October 12th. The firm presently has a “neutral” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 11.54% from the stock’s previous close.

LXS has been the subject of a number of other reports. Jefferies Financial Group set a €69.00 ($80.23) price objective on Lanxess and gave the stock a “neutral” rating in a research report on Thursday, August 2nd. Nord/LB set a €74.00 ($86.05) target price on Lanxess and gave the company a “neutral” rating in a research report on Wednesday, August 8th. Baader Bank set a €65.00 ($75.58) target price on Lanxess and gave the company a “sell” rating in a research report on Thursday, August 2nd. Deutsche Bank set a €68.00 ($79.07) price objective on Lanxess and gave the stock a “neutral” rating in a research report on Friday, September 21st. Finally, UBS Group set a €76.00 ($88.37) price objective on Lanxess and gave the stock a “buy” rating in a research report on Thursday, August 9th. Three analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have issued a buy rating to the stock. Lanxess currently has a consensus rating of “Hold” and an average target price of €73.67 ($85.67).

Shares of ETR:LXS opened at €57.38 ($66.72) on Friday. Lanxess has a 12-month low of €59.89 ($69.64) and a 12-month high of €74.50 ($86.63).

Lanxess Company Profile

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

Recommended Story: Understanding Compound Annual Growth Rate (CAGR)

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.